Latest news with #QatarFoundation
Zawya
22 minutes ago
- Business
- Zawya
Qatar Career Development Center showcases national expertise at NCDA Global Career Conference in the US
Doha, Qatar – Qatar Career Development Center (QCDC), founded by Qatar Foundation (QF), participated in the prestigious National Career Development Association (NCDA) 2025 Global Career Development Conference in Atlanta, USA, reinforcing Qatar's growing influence as a regional leader in career guidance and youth empowerment. Representing the Center was Mohammed A. AlYafei, Head of Career Programs and Services, who delivered a presentation highlighting QCDC's pioneering efforts to promote experiential learning through job-shadowing and hands-on training programs. Among the initiatives featured were 'Little Employee,' 'Career Village,' and 'My Career – My Future'—innovative programs designed to immerse students in real-world work environments and bridge the gap between academic learning and career readiness. AlYafei also outlined QCDC's integral national role in building Qatar's career development ecosystem, stressing the Center's commitment to aligning key stakeholders across the education, labor, and policy sectors to develop a unified, future-ready framework for career guidance. The NCDA Global Conference is a leading international platform for exchanging best practices and innovations in the field of career development. QCDC's participation reflects the center's broader strategy to foster knowledge-based development and promote lifelong learning in alignment with Qatar National Vision 2030. By advancing human capital development and empowering youth to navigate a dynamic labor market, QCDC directly supports the national goal of achieving a diversified and sustainable economy. 'Participating in international forums like NCDA enables us to exchange insights, build strategic partnerships, and position Qatar as a hub for forward-thinking career development,' said AlYafei. 'By sharing our programs and vision, we contribute to the global dialogue on preparing youth for tomorrow's world of work.' QCDC's presence at NCDA 2025 forms part of its ongoing international engagement strategy, aimed at capacity building, innovation, and reinforcing Qatar's leadership in sustainable human development. Qatar Career Development Center Qatar Career Development Center, founded by Qatar Foundation, aims to help the youth, particularly but not restrictedly students, across all Qatar's education system's tracks and stages, including the youth with special needs, to identify and fulfil their education and career goals. The center offers them high quality bespoke career development programs, services and activities, seeking to mobilize, educate and support them on how best to make and implement sound career decisions and plans, grow and develop professionally, and achieve their life goals in such ways that best contribute to Qatar's development and prosperity. In addition to the youth, Qatar Career Development Center targets a diverse group of individual and organizational stakeholders collectively referred to as the influencers of youth. This group primarily includes career practitioners and human capital professionals, academic advisors and administrators, parents and policy makers. The center engages them in various initiatives, projects and programs whose purpose is to educate, empower and support them in relation to their highly vital role as shapers and even definers of the youth's future.
Qatar Tribune
13 hours ago
- Health
- Qatar Tribune
Sidra Medicine contributes to breakthrough tool for early detection of Type 1 diabetes
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, has helped develop an artificial intelligence (AI) powered tool that predicts the risk of developing Type 1 Diabetes (T1D), enabling earlier diagnosis and more targeted care. The tool uses microRNA signals in the blood to detect early biological changes linked to the disease. Published in Nature Medicine, the study titled 'A microRNA-based dynamic risk score for type 1 diabetes' introduces a dynamic risk score based on microRNAs, which are tiny molecules in the blood that reflect changes in the body, including early stress in insulin-producing Beta cells. By analysing data from over 2,800 participants, the researchers found that these molecular signals could identify individuals at high risk of developing T1D long before symptoms appear. Dr. Ammira Akil, principal investigator at Sidra Medicine and director of the Metabolic and Mendelian Disorders Translational Programme, who designed the study, said: 'This study marks a significant advancement in the way we understand and manage autoimmune diseases like Type 1 Diabetes. By combining microRNA profiling with artificial intelligence, we have developed a predictive risk score that can help identify individuals at highest risk, optimise treatment decisions and determine when to intervene. It is a powerful example of how AI and Machine Learning are transforming precision medicine into real-world clinical impact.' Sidra Medicine's contribution to the study was led by the Mendelian and Metabolic Translational Research Programme under the Precision Genomics and Translational Omics Lab. The team played a keyrole in the early laboratory work on primary human insulin-producing cells and conducted critical analyses that helped with the development and validation of the clinical risk score. The study findings complement ongoing efforts at Sidra Medicine, including the DANNA1 cohort, a local foundational population-based registry of individuals with T1D in Qatar that underpin the upcoming national screening programme for early detection and prevention of Type 1 Diabetes. Prof. Khalid Fakhro, chief research officer and chair of the Precision Medicine Programme at Sidra Medicine, said: 'The study findings demonstrate that the microRNA-based dynamic risk score can accurately differentiate between individuals with and without Type 1 Diabetes. It also predicts who may become insulin dependent after an islet cell transplant and identifies patients likely to respond to specific therapies - insights that current clinical markers cannot provide. 'Importantly, this assessment is achievable through a simple, minimally invasive blood test, making it highly promising for routine clinical use. The study also reflects our ongoing commitment to advancing the use of artificial intelligence as a powerful tool to drive earlier diagnosis, more precise treatments, and safer outcomes for patients.' The next phase of the research will focus on validating the findings across broader and more diverse populations and assessing the integration of the dynamic risk score into clinical trials and early intervention strategies. Sidra Medicine will continue to support these efforts through its research programmes and ongoing collaborations. The groundbreaking study was made possible through a multinational collaboration involving experts from Sidra Medicine, Breakthrough T1D, the University of Western Sydney, and the PREDICT T1D Study Group.
Qatar Tribune
2 days ago
- Health
- Qatar Tribune
Sidra Medicine to host Women's Health Conference 2025
Sidra Medicine, a member of Qatar Foundation, will host its annual Women's Health Conference (WHC 2025) from September 26 to 27, 2025 at the Sidra Medicine auditorium in Doha. Held under the theme "Priorities in Women's Health: A Vision for the Future," the conference will provide a dedicated platform for clinical excellence, innovation, and knowledge exchange across the entire spectrum of women's healthcare. It will bring together a distinguished lineup of experts and healthcare professionals to explore the most pressing and evolving topics in the field. WHC 2025 will focus on emerging trends and challenges across prenatal diagnosis, pregnancy and childbirth, fertility, reproductive health, and women's wellness. In particular, it will examine the critical role of technology and artificial intelligence in shaping diagnostic tools, treatment pathways, and long-term care strategies for women. Chair of Women's Services at Sidra Medicine Prof. Johnny Awwad said: "This year's conference emphasizes a comprehensive and multidisciplinary approach to women's health. From puberty to menopause and everything in between, we are proud to provide a platform for open dialogue and collaborative learning among specialists who are shaping the future of women's healthcare." The two-day event will also explore how advances in digital health, predictive analytics, and minimally invasive treatments are transforming the care landscape for women in Qatar and globally. Sidra Medicine invites healthcare professionals and stakeholders to join this event, which aims to advance the conversation on women's health in Qatar and beyond, foster meaningful collaborations, ultimately shaping a healthier future for women everywhere.
Qatar Tribune
3 days ago
- Health
- Qatar Tribune
Sidra Medicine to host Women's Health Conference in September
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, will host its annual Women's Health Conference (WHC 2025) from September 26 to 27, 2025 at the Sidra Medicine auditorium in Doha, Qatar. To be held under the theme 'Priorities in Women's Health: A Vision for the Future', the conference will provide a dedicated platform for clinical excellence, innovation, and knowledge exchange across the entire spectrum of women's healthcare. It will bring together a distinguished lineup of experts and healthcare professionals to explore the most pressing and evolving topics in the field. WHC 2025 will focus on emerging trends and challenges across prenatal diagnosis, pregnancy and childbirth, fertility, reproductive health, and women's wellness. In particular, it will examine the critical role of technology and artificial intelligence in shaping diagnostic tools, treatment pathways, and long-term care strategies for women. Prof. Johnny Awwad, chair of Women's Services at Sidra Medicine, said: 'This year's conference emphasises a comprehensive and multidisciplinary approach to women's health. From puberty to menopause and everything in between, we are proud to provide a platform for open dialogue and collaborative learning among specialists who are shaping the future of women's healthcare.' The two-day event will also explore how advances in digital health, predictive analytics, and minimally invasive treatments are transforming the care landscape for women in Qatar and globally. The conference is designed to encourage the adoption of best practices and empower institutions to embrace new tools and models of care. Dr. Hala Abdullahi, senior attending physician – ObGyn, at Sidra Medicine, and co-chair of WHC 2025, said: 'We understand that women's health is not limited to clinical care. It is influenced by continuous innovation, education, and equitable access throughout every stage of life. WHC 2025 reflects our dedication to advancing this vision by creating a space for meaningful dialogue around complex and often underrepresented issues.' Sidra Medicine invites healthcare professionals and stakeholders to join this event, which aims to advance the conversation on women's health in Qatar and beyond, foster meaningful collaborations,ultimately shaping a healthier future for women everywhere. Register to secure your place at the Women's Health Conference 2025 at: Women Health Conference 2025 - Online Single Registration.
Qatar Tribune
7 days ago
- Health
- Qatar Tribune
Sidra Medicine contributes to uncovering genetic cause of rare congenital disorder
Sidra Medicine, a member of Qatar Foundation, has contributed to a groundbreaking study that uncovers new genetic causes and disease mechanisms behind Ritscher-Schinzel Syndrome (RSS), a rare multi-system congenital disorder. The study, published in Science Translational Medicine, is one of the first from the region to identify the genetic basis of RSS, marking a significant advancement in the global understanding of this condition. Titled 'Ritscher-Schinzel syndrome can be characterized as an endosomal recyclinopathy,' the study was led by researchers from Sidra Medicine, the University of Bristol, and other global partners. It used genetic, cellular, proteomic, and animal model approaches to uncover how mutations in three genes, COMMD4, COMMD9, and CCDC93, are linked to RSS. Researchers studied newly identified patient groups, including three siblings from a consanguineous Arab family enrolled in Sidra Medicine's Mendelian and Metabolic disorders Translational Research a result of their collaboration, RSS is now recognized as a 'recyclinopathy,' a disorder caused by defects in cellular recycling. (QNA) page 16
